A Case Study Of Chronic Hepatitis B C by HkMAhmad Saleemi.ppt

Hepatitis-C - 170 million people are chronic carrier of Hep-C i.e.3 % of world population. - 2-4Million Persons in USA may be Chronically affected. - 5-10 Million in Europe. - 12 Million in India - 4-6 Million in Pakistan * Source: /csr/disease/hepatitis/whocdscsrlyo2003/en/index4.html Signs Symptoms Malaise ?? ???? ? ?? ?????? Anorexia Poor appetite ???? ?? ??? Nausea ????? ???????? Abdominal pain ??? ??? Tenderness ???? Muscle Joint Pain ???????? ??? TREATMENT A. Mono therapy with alpha interferon. Work in 10 – 20 person out of 100. Side effect profile is high Dosage reduced in 40 out of 100. Treatment withdrawn in 15. Pregnant can not use. B. Combination therapy Interferon + Ribavirin Works in 30 – 40 out of 100 Ribavirin alone does not work. Serious side effects like severe anemia myocardial infarction The challenge of science Paracelsus, the Father of Pharmacology said..“All that mankind needs for good health andhealing is provided in nature..the challenge of science is to find it!” Artemisia absinthium Afsanteen Its active substances include silica, two bitter substances absinthin and anabsinthine , thujone, tannic and resinous substances, malic acid, and succinic acid. It is used medicinally as a tonic, stomachic, antiseptic, antispasmodic, carminative, cholagogue, febrifuge and anthelmintic. It has also been used to remedy indigestion. Compound medicine Majoon Dabeed ul ward Jawarish Amla Dawa ul Qurkum kabir Dawa ul Misk Sharbat Deenar Sharbat Kasni Sharbat Bazoori Hepta Care Akseer e Jiger Syrup Tab Aloe Care Cap Syrup Jigreen Actirn Tab Berisal Syrupetc Clinical Trials of Herbal medicine on Hepatitis C Patients * These patients were treated with a combination of herbal ingredients mainly glycyrrhizinate, silybum marianum, zinc compound, withinia coagulant, ginseng, Rheum emodi given in divided doses daily maximum 180 days with periodic monitoring of AST, ALT CBC. At the initial stage 10 patients completed the s